Compare · HIND vs MDLN
HIND vs MDLN
Side-by-side comparison of Vyome Holdings Inc. (HIND) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HIND and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $44.15B, about 2912.5x HIND ($15.2M).
- Over the past year, HIND is down 79.5% and MDLN is down 18.2% - MDLN leads by 61.2 points.
- MDLN has been more active in the news (20 items in the past 4 weeks vs 1 for HIND).
- MDLN has more recent analyst coverage (25 ratings vs 0 for HIND).
PerformanceHIND-45.92%MDLN-18.22%
2025-12-17+0.00%2026-06-08
- Company
- Vyome Holdings Inc.
- Medline Inc.
- Price
- $2.12-4.50%
- $33.31-0.86%
- Market cap
- $15.2M
- $44.15B
- 1M return
- -2.97%
- -20.67%
- 1Y return
- -79.46%
- -18.22%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2016
- 2025
- News (4w)
- 1
- 20
- Recent ratings
- 0
- 25
Latest HIND
- Vyome Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by Vyome Holdings Inc.
- Vyome Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Vyome Presents Transformational VT-1953 Phase 2 Clinical Study Data at Prestigious AACR 2026
- Vyome to Present Compelling Phase 2 Clinical Data on VT-1953 for Treatment of MFW at AACR 2026
- SEC Form DEF 14A filed by Vyome Holdings Inc.
- Vyome Reports Transformational 2025 Results: Company Well Positioned for Breakout Phase
- SEC Form PRE 14A filed by Vyome Holdings Inc.
- SEC Form 10-K filed by Vyome Holdings Inc.
- Vyome Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)
- Director Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)
- Large owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Large owner Bcp 8 Holdings Mozart Manager L.L.C. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Medline's Prime Vendor model expands outside the United States
- Medline Inc. announces closing of upsized secondary offering of Class A common stock
- Medline announces participation in upcoming investor conferences
- MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Large owner Bx Mozart Ml-1 Holdco L.P. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)